The Impact of DDI on the Cancer Patient
Cancer patients are often prescribed more than one drug and the need to elucidate potential harmful interactions...
Past webinars
The prevalence of potential drug–drug interactions in cancer patients treated with anticoagulants
During the ICTHIC webinar, “Long-term treatment & DDI implications in the management of CAT,” Dr. Tzu-Fei Wang...
Management of the incidents of VTE in cancer patients
During the ICTHIC webinar, “Updates in cancer-associated thrombosis,” Dr. Luis Jara-Palomares gave a lecture on the...
Management of VTE beyond 12 months in patients with cancer-associated thrombosis
During the ICTHIC webinar, “Long-term treatment & DDI implications in the management of CAT,” Dr. Luis...
Real-world CAT patient profile from the RIETE registry
During the ICTHIC webinar, “What is the profile of the real-world CAT patient?”, Dr. Laurent Bertoletti gave a...
Chronic Kidney disease in CAT patients
During the ICTHIC webinar, “What is the profile of the real-world CAT patient?” Dr. Corinne Isnard Bagnis gave a...
Thrombosis management in hematological cancers vs solid tumors: what are the differences?
During the ICTHIC webinar “CAT management: challenges in different cancer populations,” Prof Darko Antic...
Management and safety considerations in specific sub-populations of patients with cancer
During the ICTHIC webinar “CAT management: challenges in different cancer populations”, Prof Walter Ageno gave a...
What information should be given to patients with cancer, and when should it be given on the cancer care pathway?
During the ICTHIC webinar “Joint forces: the Patient & the Multi-disciplinary Team working together to...
Improving CAT awareness and patient outcomes: EMPOWER
During the ICTHIC webinar “Joint forces: the Patient & the Multi-disciplinary Team working together to...